v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss before income tax $ (25,810) $ (373,586)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, amortization, and accretion 3,413 21,688
Impairment and other charges 0 415,897
Non-cash income (937) (646)
Deferred taxes 0 397
Change in fair value of Earnout Shares liability and Warrant liability (5,034) (74,165)
Change in Tax Receivable Agreement liability 0 (21,317)
Share-based compensation expense 8,841 10,196
Changes in operating assets and liabilities:    
Interest receivable 563 (1,416)
Prepaid expenses and other current assets 2,294 (306)
Other long-term assets 241 (263)
Accounts payable (1,091) (2,243)
Accrued liabilities (3,431) 2,442
Due to related parties (30,152) 2,948
Net cash used in operating activities (51,103) (20,374)
Cash flows from investing activities:    
Purchases of available-for-sale securities (81,422) (24,670)
Maturities of available-for-sale securities 73,400 25,350
Purchase of property, plant and equipment (8,201) (8,931)
Capitalized software (109) (513)
Net cash used in investing activities (16,332) (8,764)
Cash flows from financing activities:    
Issuance of Class A Common Stock under share-based compensation plans 160 0
Payment of tax withholdings on vested share-based payment awards (184) 0
Payments on finance lease obligations (49) (50)
Net cash used in financing activities (73) (50)
Net decrease in cash, cash equivalents, and restricted cash (67,508) (29,188)
Cash, cash equivalents, and restricted cash, beginning of period 201,857 331,676
Cash, cash equivalents, and restricted cash, end of period 134,349 302,488
Supplemental cash flow information:    
Cash paid for interest 3 9
Supplemental non-cash investing and financing activities:    
Change in accruals for capital expenditures 304 254
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheet:    
Cash and cash equivalents 133,146 300,030
Restricted cash 1,203 2,458
Total cash, cash equivalents, and restricted cash $ 134,349 $ 302,488